Secondary Glomerulonephritis With Peripheral Arterial Disease Due To Systemic Lupus Erythematosus

Erika Yusticia Handayani; Ligat Pribadi Sembiring

Authors

Erika Yusticia Handayani Department of Internal Medicine, Faculty of Medicine, University of Riau, Arifin Achmad General Hospital, Riau
Ligat Pribadi Sembiring Department of Internal Medicine, Faculty of Medicine, University of Riau, Arifin Achmad General Hospital, Riau

Keywords:

glomerulonephritis,, peripheral artery disease, systemic lupus erythematosus

Abstract

Glomerulonephritis (GN) is a heterogeneous disorder characterized by glomerular compartment damage of the nephron mediated by autoimmunity. Secondary GN can occur for the patients with systemic autoimmune disease and has higher prevalence of peripheral artery disease. Symptoms and signs of GN are characterized by periorbital oedema accompanied by leg oedema, massive proteinuria, decreased renal function, hypertension, hematuria and erythrocyte casts. We reported a 40 years old female patient found with anasarca oedema, pain in the right foot, and proteinuria who had a history of systemic lupus erythematosus for 7 years. On physical examination, we found hypertensive urgency, anasarca oedem and blackish ulcus on the dorsal pedis extremity dextra. Laboratory data showed hypoalbuminemia, hypernatremia, creatinine clearance 19.38 ml/min, and albumin creatinine ratio 18.949 mg albumin/gr cr, ANA profile arthritis + 4.2. Urynalysis showed massive proteinuria, erythrocytes and casts were present. CT angiography showed the impression of peripheral artery disease.

References

Anders, H. J., Kitching, A. R., Leung, N., & Romagnani, P. (2023). Glomerulonephritis: immunopathogenesis and immunotherapy. In Nature Reviews Immunology (Vol. 23, Issue 7). https://doi.org/10.1038/s41577-022-00816-y

Buku ajar ilmu penyakit dalam, edisi VI. (n.d.).

Casuscelli, C., Longhitano, E., Maressa, V., Di Carlo, S., Peritore, L., Di Lorenzo, S., Calabrese, V., Cernaro, V., & Santoro, D. (2023). Autoimmunity and Infection in Glomerular Disease. In Microorganisms (Vol. 11, Issue 9). https://doi.org/10.3390/microorganisms11092227

Chau L B Ho, Hui J Chih, Pranav S Garimella, Kunihiro Matsushita, Shirley Jansen, Christopher M ReidChau L B Ho, Hui J Chih, Pranav S Garimella, Kunihiro Matsushita, Shirley Jansen, C. M. R. (2021). Prevalence and risk factors of peripheral artery disease in a population with chronic kidney disease in Australia: A systematic review and meta-analysis. Nephrology (Carlton), 26(10), 798–808. https://doi.org/10.1111/nep.13914

Chen, Y., Zhang, L., Xue, Q., & Wang, N. (2022). Infection profile and risk factors for mortality in patients with end-stage renal disease attributable to systemic lupus erythematosus: a two-center integrated study. Journal of International Medical Research, 50(8). https://doi.org/10.1177/03000605221118702

Choung, H. Y. G., & Grewal, R. (2022). Autoimmunity in Infection-Related Glomerulonephritis. Glomerular Diseases, 3(1). https://doi.org/10.1159/000528712

Efros, O., Beckerman, P., Basson, A. A., Cohen, R., Klang, E., Frenkel Nir, Y., Soffer, S., Barda, N., & Grossman, E. (2023). Fluctuations in Serum Creatinine Levels during Hospitalization and Long-Term End-Stage Kidney Disease and Mortality. JAMA Network Open, 6(8). https://doi.org/10.1001/jamanetworkopen.2023.26996

Foster, M. H., & Ord, J. R. (2019). Emerging immunotherapies for autoimmune kidney disease. In Human Vaccines and Immunotherapeutics (Vol. 15, Issue 4). https://doi.org/10.1080/21645515.2018.1555569

Gamal, S. M., Mohamed, S. S., Tantawy, M., Siam, I., Soliman, A., & Niazy, M. H. (2021). Lupus-related vasculitis in a cohort of systemic lupus erythematosus patients. Archives of Rheumatology, 36(4). https://doi.org/10.46497/ARCHRHEUMATOL.2021.8804

Gilbert, S. J. & D. E. W. (2018). National Kidney Foundation’ s Primer on Kidney Diseases (6th ed.). https://doi.org/https://doi.org/10.1016/C2015-0-05403-X

KDIGO Clinical practice guideline for the evaluation and management of chronic kidney disease 2023. (2023).

KDIGO Clinical Practice Guideline for the Management of Glomerular Disease 2021. (2021).

Kim, H., Hyun, Y. Y., Joo, Y. S., Yun, H. R., Kim, Y., Jung, J. Y., Jeong, J. C., Kim, J., Park, J. T., Yoo, T. H., Kang, S. W., Oh, K. H., & Han, S. H. (2024). Proteinuria, measured or estimated albuminuria for risk prediction in patients with chronic kidney disease? Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association, 39(3). https://doi.org/10.1093/ndt/gfad195

Leone, P., Prete, M., Malerba, E., Bray, A., Susca, N., Ingravallo, G., & Racanelli, V. (2021). Lupus vasculitis: An overview. In Biomedicines (Vol. 9, Issue 11). https://doi.org/10.3390/biomedicines9111626

Ovwasa, H., Aiwuyo, H. O., Okoye CA, ‪Ogochukwu, Umuerri, E. M., Obasohan, A., Unuigbe, E., & Rajora, N. (2023). Prevalence and Predictors of Peripheral Vascular Disease Amongst Predialysis Hypertensive Chronic Kidney Disease Patients in Southern Nigeria. Cureus. https://doi.org/10.7759/cureus.36752‬‬

Qi, J., Wu, T., Wang, J., Zhang, J., Chen, L., Jiang, Z., Li, Y., Jiang, H., Sun, Q., Gu, Q., & Ying, Z. (2024). Research trends and frontiers in lupus nephritis: a bibliometric analysis from 2012 to 2022. International Urology and Nephrology, 56(2). https://doi.org/10.1007/s11255-023-03715-w

Selly Septi Fandinata, Rizky Darmawan, Primanitha Ria Utami, N. M. U. (2022). Monitoring Kidney Function Through the Use of Candesartan, Telmisartan or Valsartan Antihypertensive Therapy towards Patients CKD. Media Kesehatan Masyarakat Indonesia, 18(1).

Shah, J., Luthra, K., Ghumman, G. M., Al-Dabbas, M., Ahsan, M., Avula, S., Ali, S. S., Kabour, A., & Singh, H. (2022). Impact of systemic lupus erythematosus on in-hospital outcomes of peripheral artery disease—insight from the National Inpatient Sample database. In Baylor University Medical Center Proceedings (Vol. 35, Issue 6). https://doi.org/10.1080/08998280.2022.2096361

Tejera, D., Varela, F., Acosta, D., Figueroa, S., Benencio, S., Verdaguer, C., Bertullo, M., Verga, F., & Cancela, M. (2017). Epidemiology of acute kidney injury and chronic kidney disease in the intensive care unit. Revista Brasileira de Terapia Intensiva, 29(4). https://doi.org/10.5935/0103-507X.20170061

Vaglio, A., Gattorno, M., McAdoo, S., Obici, L. P., & Ghiggeri, G. M. (2023). Editorial: The kidney in auto-immune and auto-inflammatory processes: Definitions, mechanisms, and biomarkers. In Frontiers in Medicine (Vol. 9). https://doi.org/10.3389/fmed.2022.1129021